Open Access

EDITORIAL

Kevin R. Loughlin
Canadian Journal of Urology, Vol.30, No.1, pp. 11402-11403, 2023
Abstract This article has no abstract. More >

View

24

Download

34

Open Access

LEGENDS IN UROLOGY

Pramod C. Sogani
Canadian Journal of Urology, Vol.30, No.1, pp. 11404-11406, 2023
Abstract This article has no abstract. More >

View

26

Download

37

Open Access

BOOK REVIEW

Kate H. Moore
Canadian Journal of Urology, Vol.30, No.1, pp. 11407-11407, 2023
Abstract This article has no abstract. More >

View

25

Download

43

Open Access

ARTICLE

Alexis E. Te¹, Christina Sze¹, Steven A. Kaplan², Bilal Chughtai¹
Canadian Journal of Urology, Vol.30, No.1, pp. 11408-11413, 2023
Abstract Introduction: A common indication for benign prostate hyperplasia (BPH) therapies is failure to improve with medical therapy. However, pivotal Federal Drug Administration (FDA) registered randomized clinical trials (RCTs) for minimally invasive surgical therapies (MISTs) are designed to be compared to either sham or placebo while off medical therapy at baseline, and as an alternative to medical therapy. There are few if any RCTs reporting the MISTS efficacy in patients with true medical therapy failure. We report on the efficacy of robotic water jet ablation therapy (RWT) and TURP in patients who have failed to improve with… More >

View

26

Download

46

Open Access

ARTICLE

Eric Robinson¹, Alex Wang², Solange Bassale³, Jyoti D. Chouhan²
Canadian Journal of Urology, Vol.30, No.1, pp. 11414-11418, 2023
Abstract Introduction: To evaluate the effectiveness of a standardized multimodal pain pathway for gender affirming orchiectomy (GAO) in adequately addressing postoperative pain while reducing the prescribing of unnecessary opioids.
Materials and methods: A standardized discharge pain pathway for GAO +/- scrotectomy or testicular implants was implemented between May 2020 and March 2022. A retrospective analysis was performed on all consecutive patients who underwent GAO with a single surgeon. Patients answered five questions on postoperative pain management at their 3 week follow up.
Results: A total of 69 patients were included in the study. Mean age was 34.3 years (SD… More >

View

26

Download

38

Open Access

ARTICLE

Samuel Otis-Chapados, Thomas de los Reyes, Ahmad Mousa, Gagan Fervaha, Sidney B. Radomski
Canadian Journal of Urology, Vol.30, No.1, pp. 11419-11423, 2023
Abstract Introduction: To determine whether larger artificial urinary sphincters (AUS) cuff sizes of ≥ 5.0 cm have an impact on urinary incontinence after AUS implantation as compared to cuff sizes ≤ 4.5 cm.
Materials and methods: A retrospective chart review of AUS implants performed at our institution from 1991 to 2021. Medical records were reviewed for demographics including body mass index (BMI), cause of incontinence, pelvic radiation, valsalva leak point pressure (VLPP), degree of leakage preoperatively and at 1-year post-AUS surgery, AUS revisions, erosion rate and the need for adjunct medication postoperatively.
Results: A total of 110 patients were… More >

View

22

Download

38

Open Access

ARTICLE

Adel Arezki^1,*, Iman Sadri^1,*, Ahmed S. Zakaria², Felix Couture³, David-Dan Nguyen⁴, Pierre Karakiewicz⁵, Dean S. Elterman⁶, Kevin C. Zorn²
Canadian Journal of Urology, Vol.30, No.1, pp. 11424-11431, 2023
Abstract Introduction: This study aims to report age-stratified potency outcomes in men undergoing robot-assisted radical prostatectomy (RARP).
Materials and methods: A retrospective review was performed on a database of 1737 patients who underwent RARP for localized prostate cancer between 2007 and 2019. Inclusion criteria consisted of patients undergoing bilateral nerve-sparing RARP. Exclusion criteria were preoperative Sexual Health Inventory for Men (SHIM) score < 17 and postoperative androgen deprivation therapy or radiotherapy. Patients were divided into four cohorts based on age: ≤ 54 years (group 1); 55-59 years (group 2); 60-64 years (group 3) and ≥ 65 years (group… More >

View

27

Download

49

Open Access

ARTICLE

Steven P. Rowe^1,2,3, Andrew F. Voter^1,4, Rudolf A. Werner^1,5, Katherine A. Zukotynski^6,7,8, Martin G. Pomper^1,2,3, Michael A. Gorin⁹, Lilja B. Solnes^1,3
Canadian Journal of Urology, Vol.30, No.1, pp. 11432-11437, 2023
Abstract Prostate-specific membrane antigen (PSMA)-targeted positron emission tomography (PET) is rapidly becoming widely accepted as the standard-of-care for imaging of men with prostate cancer. Labeled indications for regulatoryapproved agents include primary staging and recurrent disease in men at risk of metastases. The first commercial PSMA PET agent to become available was 18F-DCFPyL (piflufolastat F 18), a radiofluorinated small molecule with high-affinity for PSMA. The regulatory approval of 18F-DCFPyL hinged upon two key, multi-center, registration trials, OSPREY (patient population: highrisk primary staging) and CONDOR (patient population: biochemical recurrence). In this manuscript, we will (1) review key findings More >

View

30

Download

40

Open Access

ARTICLE

Elizabeth Ellis¹, Lauren Gochenaur¹, Helena Temkin-Greener², Jean Joseph¹, Divya Ajay¹
Canadian Journal of Urology, Vol.30, No.1, pp. 11438-11444, 2023
Abstract Introduction: Due to COVID-19, telemedicine has become a common method of healthcare delivery. Our goal was to evaluate urology patients’ satisfaction with telemedicine, examine patient preferences, and identify opportunities for improvement in readiness, access, and quality of care.
Materials and methods: A total of 285 adult urology patients who completed at least one telemedicine visit from September to December 2020 were eligible. A paper survey was disseminated by postal mail with an option to complete electronically. Those who returned completed surveys received a $15 gift card.
Results: Seventy-six subjects completed the survey (response rate of 27%). The most… More >

View

25

Download

38

Open Access

RESIDENT’S CORNER

Faris Najdawi¹, Shreya Lamba², Osamah Hasan¹, Patricia Vidal¹, Ryan Dobbs¹
Canadian Journal of Urology, Vol.30, No.1, pp. 11445-11447, 2023
Abstract Blastomyces dermatitidis is an environmental fungus endemic to parts of Eastern North America that notably causes pulmonary infection in humans and other animals with the potential for extrapulmonary spread, particularly in immunocompromised hosts. However, it rarely presents with genitourinary (GU) tract involvement. Herein, we present a unique case of a 37-year-old immunocompetent male with genitourinary blastomycosis with the initial presentation of a scrotal abscess. More >

View

24

Download

37

Open Access

HOW I DO IT

Roseanne Ferreira¹, Kevin C. Zorn², Naeem Bhojani², Bilal Chughtai³, Dean S. Elterman⁴
Canadian Journal of Urology, Vol.30, No.1, pp. 11448-11452, 2023
Abstract Penthrox is a portable handheld inhaler that delivers a low dose of methoxyflurane - an anesthetic with analgesic effects, rapid onset of action, and a favorable side-effect profile. It has been widely used for acute pain management in Australia for the past 40 years. Currently, it is approved for use in over 55 countries, including Canada. Prospective randomized studies highlight Penthrox analgesic effectiveness and safety profile for emergency, prehospital and outpatient settings. In addition, the use of multimodal analgesia, specifically Penthrox, can play an important role in the analgesic management of urological procedures, such as More >

View

25

Download

42

Open Access

HOW I DO IT

Flávio Vasconcelos Ordones^1,2,3, Lodewikus Vermeulen^1,3, Morgan Bressington¹, Abilash Menon¹, Timothy Burns¹, Loretta Muller¹, Mark Fraundorfer¹, Peter J. Gilling^1,4
Canadian Journal of Urology, Vol.30, No.1, pp. 11453-11456, 2023
Abstract Transperineal prostate biopsy (TPPB) is proven to be an effective diagnostic tool for prostate cancer detection. It allows satisfactory sampling of apical and anterior areas which is not well achieved with the transrectal route, without the associated risks of urinary tract infection or sepsis.
The main objective of this paper is to describe the technique utilized in our institution to perform transperineal prostate biopsy under local anesthetic in the outpatient clinic setting. More >

View

29

Download

45